SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
416On timelines for a partnership: R788 final QTc data are expected soon (late Jan/idos-1/14/2009
415Hey, td, Thanks for dropping by . . . >>R788 vs. R406. I tuck-1/14/2009
414R788 vs. R406. I believe R788 is actually a prodrug of R406, not a simple refortommysdad-1/13/2009
413>>Any idea who it might be or potential terms?<< No, not really. tuck-1/13/2009
412Thanks for the timely and helpful reply Tuck. That alleviates any near-term conmcbio-1/13/2009
411Howdy, mcbio, R788 is the oral solid reformulation of R406. I haven't seentuck-1/13/2009
410Tuck, I want to jump back to this with a few additional questions I probably shomcbio-1/13/2009
409SeekingAlpha: Rigel Still on Track, And Has Pfizer Found Its Next Blockbuster? bmopgcw-1/8/2009
408I should also mention Accutane. The drug causes very serious birth defects but mcbio-12/30/2008
407Tuck, Certainly not good news but, like you say, I think it means only that themcbio-12/30/2008
406[R788: Developmental toxicity associated with receptor tyrosine kinase Ret inhibtuck-12/26/2008
405Rigl believes the hyper-tension not overwhelming, and can be ameliorated by combmopgcw-12/15/2008
404Thanks George. The numbers for Enbrel are from a PDF on RIGL's Web site thamcbio-12/14/2008
403mexico results were higher, but the starting baseline was higher too, so they admopgcw-12/14/2008
402I posted the information below on Investors Hub. Do you feel this is an accuratmcbio-12/14/2008
401Citi: Rigel 12/7/08 Positive Phase II Data of R788 in Refactory/Relapsed mopgcw-12/13/2008
400Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-CelLJM-12/7/2008
399Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphomopgcw-12/6/2008
398Citi: November 2008 - 8 pages Rigel (RIGL) mopgcw-11/13/2008
397i read it too. This guy is averaging it down,,, His portfolio up tho!mlkr-11/10/2008
396SeekingAlpha: Rigel Pharmaceuticals: Biotech Crisis or Opportunity? by: Ohad Hammopgcw-11/10/2008
395Rigel Announces Third Quarter 2008 Financial Results and Clinical Update PR Newsmopgcw-11/8/2008
394CS: Rigel Pharmaceuticals Inc. (RIGL) Outperform [V] M. Aberman CP: US$ 8.71 TP:mopgcw-11/5/2008
393 >>Arthritis Rheum. 2008 Oct 30;58(11):3309-3318. [Epub ahead of print] tuck-11/3/2008
392Rigel to Host Update Conference Call Friday October 31, 5:43 pm ET SOUTH SAN Fmopgcw-11/1/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News